Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
NCT05477277

Adverse Outcomes and Mortality in Liver Transplant

Led by Mayo Clinic · Updated on 2025-08-15

100

Participants Needed

1

Research Sites

243 weeks

Total Duration

On this page

Sponsors

M

Mayo Clinic

Lead Sponsor

A

Amra Medical AB

Collaborating Sponsor

AI-Summary

What this Trial Is About

Prospective natural history pilot study to explore the link between muscle composition using an MRI-based Muscle Assessment Score (MAsS) and adverse outcomes in liver transplant candidates.

CONDITIONS

Official Title

Adverse Outcomes and Mortality in Liver Transplant

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patients with end-stage liver disease undergoing liver transplant evaluation
  • Patients clinically indicated for MRI during transplant evaluation
  • Adults aged 18 years or older
Not Eligible

You will not qualify if you...

  • Contraindications to MRI

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Mayo Clinic Arizona

Phoenix, Arizona, United States, 85259

Actively Recruiting

Loading map...

Research Team

L

Latasha Bunkley

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Adverse Outcomes and Mortality in Liver Transplant | DecenTrialz